发明名称 ASPIRIN-COMPRISING MEDICINAL COMPOSITIONS
摘要 FIELD: organic chemistry, medicine, pharmacy. ^ SUBSTANCE: invention relates to a pharmaceutical composition used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. As active components the composition comprises 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin. Also, invention relates to a set used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism that comprises 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin for simultaneous or successive administration, to using 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin in preparing a medicinal agent used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism, to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. Method involves administration the indicated pharmaceutical composition in pharmacologically active doses in warm-blooded animals and to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism involving the simultaneous or successive administration of this composition in warm-blooded animals. Invention provides effective inhibition of thrombosis due to potentiation of effects and enhanced effectiveness in treatment of diseases caused by thrombosis and thromboembolism. ^ EFFECT: valuable medicinal properties of compositions. ^ 20 cl, 2 tbl, 1 dwg, 2 ex
申请公布号 RU2262933(C2) 申请公布日期 2005.10.27
申请号 RU20030118638 申请日期 2001.12.20
申请人 发明人
分类号 A61K31/4365;A61K31/616;A61K45/06;A61P7/02 主分类号 A61K31/4365
代理机构 代理人
主权项
地址